top of page

mRESVIA Dispersion for Injection in Pre-Filled Syringe 50mcg/0.5ml

Product details

Registration number: SIN17482P

Classification: Prescription Only

Active ingredients: RNA-100-AR02 (mRNA-1345 encoding RSV F glycoprotein in prefusion conformation)

Strength: 0.050mg/0.5ml dose

Dosage form: INJECTION, SOLUTION

Route: INTRAMUSCULAR

Registrant: MODERNA BIOTECH SINGAPORE PTE. LTD.

ATC code: J07BX05

HSA approval date: 6 March 2026

Manufacturer(s):

  • ModernaTX, Inc. (manufacturer of LMX-100 and mRNA-1345 LNP)
  • Rovi Pharma Industrial Services, S.A. (Rovi JC)

Manufacturing country/countries: UNITED STATES; SPAIN

What are the HSA registration number and classification for mRESVIA Dispersion for Injection in Pre-Filled Syringe 50mcg/0.5ml?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN17482P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for mRESVIA Dispersion for Injection in Pre-Filled Syringe 50mcg/0.5ml?

According to the HSA dataset updated 7 August 2026:

Active ingredients: RNA-100-AR02 (mRNA-1345 encoding RSV F glycoprotein in prefusion conformation)

Strength: 0.050mg/0.5ml dose

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for mRESVIA Dispersion for Injection in Pre-Filled Syringe 50mcg/0.5ml?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, SOLUTION

Route: INTRAMUSCULAR

Source for this answer

Who is the recorded registrant for mRESVIA Dispersion for Injection in Pre-Filled Syringe 50mcg/0.5ml?

According to the HSA dataset updated 7 August 2026:

Registrant: MODERNA BIOTECH SINGAPORE PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for mRESVIA Dispersion for Injection in Pre-Filled Syringe 50mcg/0.5ml?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • ModernaTX, Inc. (manufacturer of LMX-100 and mRNA-1345 LNP)
  • Rovi Pharma Industrial Services, S.A. (Rovi JC)

Manufacturing country/countries: UNITED STATES; SPAIN

Source for this answer

Where can I look up mRESVIA Dispersion for Injection in Pre-Filled Syringe 50mcg/0.5ml in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN17482P or the exact product name mRESVIA Dispersion for Injection in Pre-Filled Syringe 50mcg/0.5ml. The general register link does not preselect this product.

Source for this answer

What are the source dates for this mRESVIA Dispersion for Injection in Pre-Filled Syringe 50mcg/0.5ml record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this mRESVIA Dispersion for Injection in Pre-Filled Syringe 50mcg/0.5ml record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN17482P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page